In 16 years of supporting life science companies in raising capital and structuring deals with the pharma industry, I never felt that venture capital exists in abundance on the European market.
It always seemed that the market is very VC-friendly on the European stage - plenty of teams and technology meet with a scarcity of available funds.
This was the reason to start the LSG2G Lunch MeetUps in June 2017. I remember our first meetup with 15 Life Science Enthusiasts like Pharma Business Developer, Life Science Investors, Life Science Entrepreneurs, and Service Partners. We discussed the state of Investments in Biotech in Europe.
As the first meetup was well received, the LSG2G Partners organized one every three months, an investment conference, and during the pandemic, created a podcast.
Availability of Venture Capital in Europe
According to Dealroom.co 2017, the transaction volume in life science companies in 2017 was about 3,7 billion euros.
In 2020 investments increased to 6 billion Euros, which was already achieved by July this year. It looks promising to see investments double since we started the LSG2G initiative in the last four years.
Sebastien Groyer - 20 Years Experience in Life Science Venture Investments
So far, to the analytics of Venture Investments in Biotech in Europe. Numbers are fine but leave a few important questions open.
Who are the people behind those numbers?
What stories did they write in their career?
What lessons did they learn in the world of VC Investments?
Business is always done between people, and sharing stories helps to understand how an industry works and how deep tech can be transformed into products that help the patients.
I am delighted to welcome to this episode Sebastien Groyer who brings 20 years of profound investment expertise to the conversation table. In this episode, he will share
7 Tales from 20 Years of Deep Tech Life Science Investments
and also will tell why he turned into a serial entrepreneur in 2021.
Video to this Episode:
Timestamps:
00:00 Introduction
02:35 How do VCs view planning in companies?
05:59 How to Approach Investors when Plans Change
11:00 What are Target Companies of VCs?
15:15 Are VCs Going for First Movers or Rather Established Markets?
19:30 How Detailed Should Business Plans be when Pitching to VCs?
23:50 Storytelling – From Rough to Detail
27:15 The Reality of VC Life
34:40 How Often Can You Follow Up with VCs before Ending Up on a Blacklist
38:54 What is the Right Time to Approach VCs?
40:40 How do VCs view companies in Fundraising Mode?
46:10 The Fundraising Process in a Company
48:15 Is the Fundraisngprocess Transactional, or do Relationships matter?
51:00 Fundraising – Similarities and Differences between the US and the European Approach
56:50 Entrepreneurship and Investors – Lifestyle or a Job?
01:00:00 The Role of Money in Different Societies
01:04:00 Why Do VCs Search for Exits?
01:11:00 Valuation Expectations of VCs
01:14:00 It is all about growth
01:19:00 When Does it Make Sense to Reach out to VCs?
01:23:00 Differences in the Value of Information in the B2B and B2C world
01:27:00 The Pros and Cons of being an Investor or Entrepreneur
01:30:00 Spirituality, Investment, and Entrepreneurship
01:34:30 What is the most important thing to consider when reaching out to VCs?
Join Our Conversations:
I am delighted to announce that the LSG2G Partner, Diagnostics Expert, and Business Angel Albert Missbichler invites us to a Get2gether in his wine cellar in the Vineyards of Vienna.
When? October 10, 2021 - 3:30 PM
Where? Stammersdorfer Kellergasse 106, 1210 Vienna - Austria
Price? EUR 28,- for buffet and welcome drink (payment at the event)
Music? Jazz, Viennese Chants, and Opera
Due to the current corona measures, the event is limited to 50 guests, and the latest corona rules apply. Please make sure that you are either vaccinated or have a negative PCR test result to participate in this event.
First, come - first serve principle.
It would be great to welcome you in person - Albert Missbichler and Christian Soschner will be there.
Interested?
Register today with a brief eMail to
Community Partner:
These companies make the community, this newsletter, and the LSG2G Podcast possible, so go check them out and thank them for their support!
You are receiving the LSG2G-Letter because you either signed up or attended one of the events organized by LSG2G. Feel free to unsubscribe if you aren’t finding this valuable.
Nothing in this email is intended to serve as financial advice. Do your own research.
7 Tales from 20 years of Deep Tech Life Science Venture Capital Investment